CSF MMP-1 and MMP-12 levels were significantly higher in OIND than in MS patients after adjusting for sex and age at study time (ANCOVA; p = 0.009 and p = 0.012, respectively) (Table 3). This evidence concerns the gene MMP1 and myeloid sarcoma.